Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis.

ABSTRACT:

Objective

Given that the coronavirus disease 2019 (COVID-19) mainly spreads through the respiratory system and is associated with severe pulmonary complications, lung cancer patients may have worse outcomes than those with other tumors. There is no confirmed evidence about the mortality comparison between COVID-19 patients with lung cancer and other tumors. We performed a systematic review and pooled analysis to provide precise estimates of the mortality rate of COVID-19 patients with lung cancer and other tumors.

Materials and methods

Our study systemically included and reviewed 13 studies on the characteristics of COVID-19 patients with lung cancer published up to November 1, 2020. The primary endpoint was all-cause mortality. We also compared the all-cause mortality rates

SUBMITTER: Lei H 

PROVIDER: S-EPMC8098047 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature